Targeting of antiviral drugs to T4-lymphocytes: anti-HIV activity of neoglycoprotein-AZTMP conjugates in vitro
- 15 December 1990
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 40 (12) , 2603-2610
- https://doi.org/10.1016/0006-2952(90)90577-8
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Covalent and Noncovalent Protein Binding of Drugs: Implications for Hepatic Clearance, Storage, and Cell-Specific Drug DeliveryPharmaceutical Research, 1989
- The Role of Mononuclear Phagocytes in HTLV-III/LAV InfectionScience, 1986
- Infection of monocyte/macrophages by human T lymphotropic virus type III.Journal of Clinical Investigation, 1986
- Binding of HTLV-III/LAV to T4 + T Cells by a Complex of the 110K Viral Protein and the T4 MoleculeScience, 1986
- AIDS-associated retroviruses (ARV) can productively infect other cells besides human T helper cellsVirology, 1985
- The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirusNature, 1984
- Selective Tropism of Lymphadenopathy Associated Virus (LAV) for Helper-Inducer T LymphocytesScience, 1984
- Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDSScience, 1984
- Uptake of neoglycoproteins via membrane lectin(s) of L1210 cells evidenced by quantitative flow cytofluorometry and drug targetingBiology of the Cell, 1984
- Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)Science, 1983